Shanghai Pharmaceutical Group Co., Ltd., National Pharmaceutical Industry Group, National Enterprise Technology Center, Fortune 500 Chinese Enterprises, and the scale of pharmaceutical retail sales are at the forefront of the national pharmaceutical retail industry.Comprehensive pharmaceutical company in the entire industry chain.
Shanghai Pharmaceutical Group Co., Ltd. is the only pharmaceutical listed company in China in China, which has a leading position in the pharmaceutical products and distribution markets.In 2012, R & D investment accounted for 4.72%of the companys pharmaceutical business sales revenue.The company has established the R & D system of the Group General Institute with the Central Research Institute. It has 1 national enterprise technology center and 10 provincial and municipal enterprise technology centers, and has been selected as a major national science and technology special project for more than ten "major new drugs".The company adopts an open research model to establish an innovative drug research and development strategic alliance with the Shanghai Academy of Sciences Shanghai Pharmaceutical, and establish a joint laboratory with China Pharmaceutical University and Shenyang Pharmaceutical University.Pharmaceuticals and other cooperation to carry out innovative drug research and development; at the same time, it also begins to enter the therapeutic antibody field through project introduction, cooperative development and other methods.Shanghai pharmaceutical manufacturing covers chemistry and biopharmaceuticals, modern Chinese medicine and health care products, medical equipment and other fields.For more than 20 types of dosage forms such as slices, capsules, powder needles (including frozen dried), small -capacity injection solution, eye drops, qi mist, gel agents, etc., over 100 million products.The companys Xinyi, Lei Shi, Dragon Tiger, Youth Bao, Hu Qingyu Tang, Cangsong, Guofeng, and Principles and many other brands are well -known trademarks in China.The companys pharmaceutical production strictly implements the requirements of Chinas new version of GMP. There are multiple raw materials or preparations that have passed the quality certification of WHO, FDA, the European Union, and other developed countries.The distribution network of Shanghai Pharmaceuticals is to radiate across the country with the three key areas of East China, North China, and South China, the most developed economy in China, and ranks second in the country.The companys distribution business is mainly for pure sales of hospitals and cooperates with more than 40 multinational pharmaceutical companies worldwide.The development of new businesses such as the companys vaccines, high -end consumables, DTP (high -value drug direct delivery) and SPD (pharmaceutical logistics management technology) is leading in China.The companys distribution service is gradually moving towards a hospital modern service solution with the supply chain extension service and clinical support services as its core to provide hospital customers with terminal solutions, special logistics and information services.Shanghai Pharmaceutical Retail has many well -known brands such as Huas, Leiyun Shang, Yu Tiancheng, Life Insurance, Raymond, and Keyuan Xinhai Pharmacy. It covers 12 provinces, municipalities and autonomous regions in 12 provinces, and 1,792 stores.In 2012, the companys pharmaceutical retail sales scale ranked among the top five in the national pharmaceutical retail industry.Shanghai Pharmaceuticals retail business includes a variety of formats such as chain pharmacies, joint pharmacies, and DTP pharmacies, and actively develop e -commerce to achieve online sales.Shanghai Medicine advocates the core values ??of corporate enterprises that "innovation, integrity, cooperation, tolerance, and responsibility". They are committed to perseverance, improve the quality of the peoples healthy life, and strive to create a respected and well -known brand drug manufacturer and health service in the industry.business.